Skip to content

Multiple Sclerosis Journal

ISSN 1477-0970, 1352-4585

4 papers in the library · 43 citations · publishing 2015-2025

Papers

Sort Most recent Most cited

Hypnosis and mindfulness audio recordings for reducing fatigue in individuals with multiple sclerosis: A randomized controlled study.

Multiple Sclerosis Journal June 1, 2025 Mark P Jensen, Susan Robles, Michael G Nash et al. 1 citation

Fatigue is a common problem in individuals with multiple sclerosis (MS). The objective was to evaluate the effects on fatigue of having 4 weeks of access to audio recordings of therapeutic hypnosis (HYP) and mindfulness meditation (MM) practices. A total of 333 individuals with MS and fatigue were randomly assigned to one of the three treatment conditions for 28 weeks: (1) access to therapeutic...

DOI: 10.1177/13524585251329820 (opens in new tab) Full text (opens in new tab) Multiple sclerosis Fatigue Hypnosis Mindfulness meditation +1

Online meditation training for people with multiple sclerosis: A randomized controlled trial.

Multiple Sclerosis Journal April 2019 Cesare Cavalera, Marco Rovaris, Laura Mendozzi et al.

Multiple sclerosis (MS) has a relevant impact on quality of life (QOL) and is associated with increased risks of psychological morbidity. Mindfulness-based interventions (MBIs) are among the most studied interventions, although few well-conducted studies have tested them in this field. Furthermore, the participation in typical MBIs may be impaired by time and logistics. We aimed to test the...

Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months: A randomized clinical trial

Multiple Sclerosis Journal July 9, 2018 Angela Senders, Douglas Allen Hanes, Dennis N. Bourdette et al. 42 citations

Background: Mindfulness training is often used as a therapeutic intervention to manage stress and enhance emotional well-being, yet trials for multiple sclerosis (MS) are limited and few have used an active control. Objective: Assess the feasibility of mindfulness-based stress reduction (MBSR) for people with MS and evaluate the efficacy of MBSR compared to an education control. Methods: We...

What to make of cannabis and cognition in MS: In search of clarity amidst the haze

Multiple Sclerosis Journal December 1, 2015 Anthony Feinstein, Emma Banwell, Bennis Pavisian

Given data showing that cannabis (herbal drug from the Cannabis sativa plant) can impair cognition in healthy subjects, the possibility that it may also do so in people with multiple sclerosis (MS) should be cause for concern. Approximately 20% of people with MS inhale or ingest cannabis for a variety of symptoms, or as a lifestyle choice. In addition, pharmaceutically manufactured cannabis (in...